Introduction Over the course of 2021, numerous key clinical trials with valuable contributions
to clinical cardiology were published or presented at major international conferences. This …

Mitral regurgitation is the second most frequent heart valve disease in Europe and the most
frequent in the US. Although surgery is the therapy of choice when intervention is indicated …

Background Patients with mitral regurgitation (MR) and morphologic presence of relevant
mitral annular calcification (MAC) represent a challenging phenotypic subset with limited …

Pathologic left ventricular remodeling and valvular heart disease may contribute to the
clinical presentation and outcomes of patients presenting with heart failure, and limit the …

BACKGROUND: Previous transcatheter valve therapy registry analyses of transcatheter
mitral valve in valve (MViV) replacement of degenerated bioprosthesis reported early …

A deep dive into the percutaneous mitral valve data : Current Opinion in Cardiology A deep
dive into the percutaneous mitral valve data : Current Opinion in Cardiology Log in or Register …

Although transcatheter aortic valve replacement (TAVR) has developed into a routine
treatment for patients with severe aortic valve stenosis, transcatheter mitral valve …

Cardiovascular diseases (CVD) are the leading cause of death in the world and one of the
most common diseases in the elderly, with high prevalence and poor prognosis, which …

mitral valve replacement (TMVR) via the valve-in-valve (ViV) technique has a unique legacy
among structural heart procedures in that approval was not based on the results of …

Background Transcatheter mitral valve replacement (TMVR) has emerged as a minimally
invasive alternative to mitral valve surgery for patients at high or prohibitive operative risk …